Silvana Figar

Silvana Figar

Auto-generated profile, based on publicly available information

Silvana Figar

Universidad Hospital Italiano de Buenos Aires

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in American Journal of Hypertension
Verified
Journal Article
Closed access
SFS Figar
S Figar
CGC Galarza
C Galarza
EPE Petrlik
E Petrlik
LHL Hornstein
L Hornstein
GRG Rodriguezloria
G Rodriguezloria
FGF Gonzalezbernaldodequiros
F Gonzalezbernaldodequiros
It is not clear which educational strategy is most effective in helping patients to change their lifestyles. This study compared the efficacy of two different educational models on reducing blood pressure (BP). This was a randomized controlled trial in ambulatory hypertensive patients >65 years of age. Workshops that aimed to develop self-management and patient empowerment (PEM) were compared to workshops that used a compliance-based model (CEM). The primary outcome was change in systolic BP at 3 months compared with basal values between groups (net reduction), measured by 24-h ambulatory BP monitoring. A total of 30 patients were educated with PEM and 30 others with CM. Both groups were statistically similar with regard to age (67 v 70 years), systolic BP (157 v 156 mm Hg) and diastolic BP (88 v 88 mm Hg), diabetes (23% v 31%), and basal natriuresis 116 v 121 mEq/day). There were more women in the PEM group (57% v 30%). The PEM group showed a significant reduction of 8 mm Hg (95% confidence interval [CI] 2 to 15), whereas the CM group showed a reduction of 3 mm Hg (95% CI -3 to 8), with a net reduction of 6 (95% CI -3 to 14). Mean net night-time systolic BP reduction was 12 mm Hg (95% CI 2 to 22). BP control was 70% in PEM group vs 45% in CM group (P = 0.045). The relative odds ratio for BP control for the PEM group after adjustment for age, sex, diabetes, basal blood pressure and changes in pharmacological treatment was 3.7 (95% CI 1.05 to 13.1). Based on these study results, the self-management education model was significantly more effective than the compliance-based model in BP control.

2 January 2011 in Cost Effectiveness and Resource Allocation
Verified
Journal Article
Open access
PDF file
GPGaston Perman
Gaston Perman
EREmiliano Rossi
Emiliano Rossi
GWGabriel D Waisman
Gabriel D Waisman
CACristina Aguero
Cristina Aguero
CGClaudio Daniel Gonzalez
Claudio Daniel Gonzalez
ESEnrique R. R. Soriano
Enrique R. R. Soriano
Mounting evidence shows that multi-intervention programmes for hypertension treatment are more effective than an isolated pharmacological strategy. Full economic evaluations of hypertension management programmes are scarce and contain methodological limitations. The aim of the study was to evaluate if a hypertension management programme for elderly patients is cost-effective compared to usual care from the perspective of a third-party payer.

16 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SFSilvana Figar
Silvana Figar
VPVanina Pagotto
Vanina Pagotto
LLLorena Luna
Lorena Luna
JSJulieta Salto
Julieta Salto
MMMagdalena Wagner Manslau
Magdalena Wagner Manslau
FQFernán González Bernaldo de Quirós
Fernán González Bernaldo de Quirós
Background: By July 1st, the incidence rate of RT-qPCR SARS-CoV-2 infection was 5.9% in Barrio Padre Mugica, one of the largest slums in Buenos Aires City. This study aimed to establish the seroprevalence of SARS-CoV-2 three months after the first case was reported. Methods: Between June 10 th and July 1 st , a cross-sectional design was carried out on people over 14 years old, selected from a probabilistic sample of households. A finger prick sample was tested by ELISA to detect IgG-class antibodies against SARS-CoV-2. Multilevel model was applied to understand sector, household and individual conditions associated with seroconvert. Results: Prevalence based on IgG was 53.4% (95%IC 52.8% to 54.1%). Among the IgG positive cases, 15% reported having compatible symptoms at some point in the past two months. There is evidence of within-household clustering effect (rho=0.52; 95% IC 0.36-0.67); living with a PCR-confirmed case doubled the chance of being SARS-CoV2 IgG positive (OR 2.13; 95% IC 1.17-3.85). The highest risk of infection was found in one of the most deprived areas of the slum, the “Bajo autopista” sector. Discussion: High seroprevalence is shown, for each symptomatic RT-qPCR-confirmed diagnosis, 9 people were IgG positive, indicating a high rate of undetected (probable asymptomatic) infections. Given that transmission among family members is a leading driver of the disease’s spread, it is unsurprising that crowded housing situations in slums are directly associated with higher risk of infection and consequently high seroprevalence levels. This study contributes to the understanding of population immunity against SARS-CoV2, its relation to living conditions and viral spread, for future decision making.

5 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
VPVanina Pagotto
Vanina Pagotto
AFAnalia Ferloni
Analia Ferloni
MSMaría Mercedes Soriano
María Mercedes Soriano
MDMorena Díaz
Morena Díaz
MGManuel Braguisnky Golde
Manuel Braguisnky Golde
SFSilvana Figar
Silvana Figar
Introduction The World Health Organization (WHO) recommends vaccination against Sars Cov-2 coronavirus to mitigate COVID-19 pandemic. On December 29th, the Argentine Ministry of Health started a vaccination plan with the Sputnik V vaccine emphasizing the registration of the Events Supposedly Attributed to Vaccines and Immunizations (ESAVI) in the National Surveillance System. The aim of this study is to determine the safety of this vaccine. Methods In an ongoing cohort study, health professionals from Hospital Italiano de Buenos Aires vaccinated with the first component of the Sputnik V vaccine (a rAd26 vector-based) were followed up. Safety at 72 hs was analysed from a self-report form. Local and systemic reactions were characterized as mild, moderate and severe. Incident rates were calculated per 1000 person-hours by age groups and gender. Adjusted hazard ratio and 95% Confidence Interval (HR; 95%CI) is obtained by Cox Regression Model. Results 707 health professionals (mean age 35, 67% female) were vaccinated, response rate was 96,6% and 71,3% reported at least one ESAVI. Rate was 6.3 per 1.000 person-hours. Among local reactions, 54% reported pain at the injection site, 11% redness and swelling. Among systemic reactions 40% reported fever, 5% diarrhea and 68% new or worsened muscle pain. Five percent had serious adverse events that required medical evaluation and one inpatient. ESAVI rate was higher among females (65.4% vs 50%; HR 1.38, 95%CI 1.13-5.38) and in younger than 55 years-old (72.8% vs 32%; HR 2.66, 95%CI 1.32-1.68). Conclusion Active surveillance on safety for vaccines with emergency approval is mandatory. This study shows high rates of local and systemic reactions however early serious events were rare. Short term safety is supported by these preliminary findings. Studies on long term safety and efficacy, accoding sex and age, are needed.

1 January 2010
Verified
Journal Article
Closed access
DBDamian Borbolla
Damian Borbolla
COCarlos Otero
Carlos Otero
DLDavid F Lobach
David F Lobach
KKKensaku Kawamoto
Kensaku Kawamoto
ASAna M Gomez Saldaño
Ana M Gomez Saldaño
FQFernan Gonzalez Bernaldo De Quiros
Fernan Gonzalez Bernaldo De Quiros

19 June 2019 in Revista de la Facultad de Ciencias Médicas de Córdoba
Verified
Journal Article
Open access
PDF file
JVJimena Vicens
Jimena Vicens
GPGastón Perman
Gastón Perman
VAValeria Aliperti
Valeria Aliperti
WMWalter Masson
Walter Masson
HSHerman Schargrodsky
Herman Schargrodsky
MOMartín O’fLaherty
Martín O’fLaherty
Objective: To quantify the contribution of risk factors and treatments in the reduction of mortality due to coronary heart disease in Argentina between 1995 and 2010.Methods: We used the validated IMPACTCHD model integrating data on effectiveness, use of treatments and changes in the risk factors between 1995 and 2010 in people older than 25 years in Argentina. The difference between the coronary deaths observed and expected in 2010 was distributed between treatments and risk factors.Results: Between 1995 and 2010, adjusted mortality rates for coronary heart disease decreased 29.8% (8,500 deaths prevented or postponed - MPP). Improvements in treatments accounted for 49.9%, mostly secondary prevention of acute myocardial infarction (8.2%); antihypertensive treatment (11.9%) and treatment of heart failure (13.2%). Improvements in risk factors accounted for 32.9% of MPPs: systolic blood pressure 34.6%; total cholesterol 12.8%; smoking 6.8%. An excess of deaths was found due to the increase in diabetes (9.4%), obesity (6.9%) and sedentary lifestyle (5%). The 17.2% of the MPPs were not explained by the model.Conclusion: One out of every two MPP due to coronary heart disease in Argentina between 1995 and 2010 was due to treatments and one third to the improvement of risk factors. The decrease in blood pressure, cholesterol and smoking was limited by increases in the prevalence of obesity, sedentary lifestyle and diabetes. This study was possible thanks to the collaborative work to the cardiovascular epidemiology.